FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1839980458> ?p ?o ?g. }

• W1839980458 endingPage "238" @default.
• W1839980458 startingPage "231" @default.
• W1839980458 abstract "This investigation sought to elucidate the relationship between hepatocyte growth factor (HGF)-induced metastatic behavior and the tyrosine kinase inhibitors (TKIs) crizotinib and dasatinib in canine osteosarcoma (OS). Preliminary evidence of an apparent clinical benefit from adjuvant therapy with dasatinib in four dogs is described.The inhibitors were assessed for their ability to block phosphorylation of MET; reduce HGF-induced production of matrix metalloproteinase (MMP); and prevent invasion, migration, and cell viability in canine OS cell lines. Oral dasatinib (0.75 mg/kg) was tested as an adjuvant therapy in four dogs with OS.Constitutive phosphorylation of MET was detected in two cell lines, and this was unaffected by 20-nM incubation with either dasatinib or crizotinib. Incubation of cell lines with HGF (MET ligand) increased cell migration and invasion in both cell lines and increased MMP-9 activity in one. Dasatinib suppressed OS cell viability and HGF-induced invasion and migration, whereas crizotinib reduced migration and MMP-9 production but did not inhibit invasion or viability.Invasion, migration, and viability of canine OS cell lines are increased by exogenous HGF. HGF induces secretion of different forms of MMP in different cell lines. The HGF-driven increase in viability and metastatic behaviors we observed are more uniformly inhibited by dasatinib. These observations suggest a potential clinical benefit of adjuvant dasatinib treatment for dogs with OS." @default.
• W1839980458 created "2016-06-24" @default.
• W1839980458 creator A5029701926 @default.
• W1839980458 creator A5036389960 @default.
• W1839980458 creator A5044057914 @default.
• W1839980458 creator A5053711327 @default.
• W1839980458 creator A5075696484 @default.
• W1839980458 date "2015-08-01" @default.
• W1839980458 modified "2023-09-27" @default.
• W1839980458 title "Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs" @default.
• W1839980458 cites W1761756383 @default.
• W1839980458 cites W1843886919 @default.
• W1839980458 cites W1900638358 @default.
• W1839980458 cites W1996635718 @default.
• W1839980458 cites W1997923564 @default.
• W1839980458 cites W1999465006 @default.
• W1839980458 cites W2002185737 @default.
• W1839980458 cites W2011017763 @default.
• W1839980458 cites W2018924811 @default.
• W1839980458 cites W2019573100 @default.
• W1839980458 cites W2042077562 @default.
• W1839980458 cites W2042323503 @default.
• W1839980458 cites W2051536771 @default.
• W1839980458 cites W2052907781 @default.
• W1839980458 cites W2058561890 @default.
• W1839980458 cites W2074198681 @default.
• W1839980458 cites W2082829529 @default.
• W1839980458 cites W2094337993 @default.
• W1839980458 cites W2100742787 @default.
• W1839980458 cites W2102929879 @default.
• W1839980458 cites W2109244653 @default.
• W1839980458 cites W2133038691 @default.
• W1839980458 cites W2137998437 @default.
• W1839980458 cites W2153871090 @default.
• W1839980458 doi "https://doi.org/10.1016/j.tranon.2015.03.006" @default.
• W1839980458 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4562978" @default.
• W1839980458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26310368" @default.
• W1839980458 hasPublicationYear "2015" @default.
• W1839980458 type Work @default.
• W1839980458 sameAs 1839980458 @default.
• W1839980458 citedByCount "7" @default.
• W1839980458 countsByYear W18399804582017 @default.
• W1839980458 countsByYear W18399804582019 @default.
• W1839980458 countsByYear W18399804582020 @default.
• W1839980458 countsByYear W18399804582021 @default.
• W1839980458 countsByYear W18399804582022 @default.
• W1839980458 crossrefType "journal-article" @default.
• W1839980458 hasAuthorship W1839980458A5029701926 @default.
• W1839980458 hasAuthorship W1839980458A5036389960 @default.
• W1839980458 hasAuthorship W1839980458A5044057914 @default.
• W1839980458 hasAuthorship W1839980458A5053711327 @default.
• W1839980458 hasAuthorship W1839980458A5075696484 @default.
• W1839980458 hasBestOaLocation W18399804581 @default.
• W1839980458 hasConcept C126322002 @default.
• W1839980458 hasConcept C137738243 @default.
• W1839980458 hasConcept C170493617 @default.
• W1839980458 hasConcept C185592680 @default.
• W1839980458 hasConcept C2776232967 @default.
• W1839980458 hasConcept C2776996007 @default.
• W1839980458 hasConcept C2779422266 @default.
• W1839980458 hasConcept C2779536868 @default.
• W1839980458 hasConcept C2779634585 @default.
• W1839980458 hasConcept C42362537 @default.
• W1839980458 hasConcept C502942594 @default.
• W1839980458 hasConcept C53227056 @default.
• W1839980458 hasConcept C54355233 @default.
• W1839980458 hasConcept C71924100 @default.
• W1839980458 hasConcept C81885089 @default.
• W1839980458 hasConcept C86803240 @default.
• W1839980458 hasConcept C98274493 @default.
• W1839980458 hasConceptScore W1839980458C126322002 @default.
• W1839980458 hasConceptScore W1839980458C137738243 @default.
• W1839980458 hasConceptScore W1839980458C170493617 @default.
• W1839980458 hasConceptScore W1839980458C185592680 @default.
• W1839980458 hasConceptScore W1839980458C2776232967 @default.
• W1839980458 hasConceptScore W1839980458C2776996007 @default.
• W1839980458 hasConceptScore W1839980458C2779422266 @default.
• W1839980458 hasConceptScore W1839980458C2779536868 @default.
• W1839980458 hasConceptScore W1839980458C2779634585 @default.
• W1839980458 hasConceptScore W1839980458C42362537 @default.
• W1839980458 hasConceptScore W1839980458C502942594 @default.
• W1839980458 hasConceptScore W1839980458C53227056 @default.
• W1839980458 hasConceptScore W1839980458C54355233 @default.
• W1839980458 hasConceptScore W1839980458C71924100 @default.
• W1839980458 hasConceptScore W1839980458C81885089 @default.
• W1839980458 hasConceptScore W1839980458C86803240 @default.
• W1839980458 hasConceptScore W1839980458C98274493 @default.
• W1839980458 hasFunder F4320306601 @default.
• W1839980458 hasIssue "4" @default.
• W1839980458 hasLocation W18399804581 @default.
• W1839980458 hasLocation W18399804582 @default.
• W1839980458 hasLocation W18399804583 @default.
• W1839980458 hasLocation W18399804584 @default.
• W1839980458 hasOpenAccess W1839980458 @default.
• W1839980458 hasPrimaryLocation W18399804581 @default.
• W1839980458 hasRelatedWork W1839980458 @default.
• W1839980458 hasRelatedWork W2045309793 @default.
• W1839980458 hasRelatedWork W2097757428 @default.

• next